WORLDWIDE sales of Omron blood pressure monitors (BPMs) recently exceeded 400 million units, with the company celebrating the "landmark achievement" in its mission to extend healthy life expectancy through preventive cardiovascular care.
The brand launched its first home blood pressure monitor in 1973, a time when all blood pressure monitoring took place in medical facilities.
"Reaching 400 million units sold is more than a number - it represents the trust that millions of people place in Omron Healthcare to support their journey toward longer, healthier lives," said Ayumu Okada, President and CEO, Omron Healthcare.
"The quality and accuracy of Omron blood pressure monitors are well recognised by healthcare professionals around the world.
"We remain dedicated to our 'Going for ZERO' vision, aiming to eradicate cerebro-cardiovascular events globally by developing technologies that connect daily life and healthcare, empowering people everywhere to take preventive action."
Recent innovations include AI-powered atrial fibrillation detection, combined blood pressure and ECG readings, and data sharing via connected digital health monitoring.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Oct 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Oct 25
